vs

Side-by-side financial comparison of CONMED Corp (CNMD) and Forestar Group Inc. (FOR). Click either name above to swap in a different company.

CONMED Corp is the larger business by last-quarter revenue ($317.0M vs $273.0M, roughly 1.2× Forestar Group Inc.). Forestar Group Inc. runs the higher net margin — 5.6% vs 4.4%, a 1.3% gap on every dollar of revenue. On growth, Forestar Group Inc. posted the faster year-over-year revenue change (9.0% vs -1.3%). Over the past eight quarters, CONMED Corp's revenue compounded faster (-2.3% CAGR vs -9.6%).

The CONMED Corporation is a publicly traded American manufacturer of medical equipment and surgical devices, primarily in the orthopedic, laparoscopic and general surgery, and patient care areas. CONMED's headquarters is in Largo, Florida. Prior to July 2022, it was in Utica, New York. CONMED embraces a people-first culture that starts with a mission to support their healthcare partners and the patients they serve. They have manufacturing facilities in the United States and Mexico, offices in...

Forestar Group Inc. is a residential lot development company based in Arlington, Texas. The company has operations in 51 markets in 21 states and delivered 11,518 residential lots during the twelve-month period ended December 31, 2020. The company is publicly traded on the New York Stock Exchange and in October 2017 became a majority-owned subsidiary of D.R. Horton, Inc., the largest homebuilder by volume in the United States since 2002. The company primarily acquires entitled real estate and...

CNMD vs FOR — Head-to-Head

Bigger by revenue
CNMD
CNMD
1.2× larger
CNMD
$317.0M
$273.0M
FOR
Growing faster (revenue YoY)
FOR
FOR
+10.3% gap
FOR
9.0%
-1.3%
CNMD
Higher net margin
FOR
FOR
1.3% more per $
FOR
5.6%
4.4%
CNMD
Faster 2-yr revenue CAGR
CNMD
CNMD
Annualised
CNMD
-2.3%
-9.6%
FOR

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CNMD
CNMD
FOR
FOR
Revenue
$317.0M
$273.0M
Net Profit
$13.8M
$15.4M
Gross Margin
57.9%
20.1%
Operating Margin
8.0%
7.6%
Net Margin
4.4%
5.6%
Revenue YoY
-1.3%
9.0%
Net Profit YoY
129.1%
-6.7%
EPS (diluted)
$0.45
$0.30

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CNMD
CNMD
FOR
FOR
Q1 26
$317.0M
Q4 25
$373.2M
$273.0M
Q3 25
$337.9M
$670.5M
Q2 25
$342.3M
$390.5M
Q1 25
$321.3M
$351.0M
Q4 24
$345.9M
$250.4M
Q3 24
$316.7M
$551.3M
Q2 24
$332.1M
$318.4M
Net Profit
CNMD
CNMD
FOR
FOR
Q1 26
$13.8M
Q4 25
$15.4M
Q3 25
$2.9M
$86.9M
Q2 25
$21.4M
$32.9M
Q1 25
$6.0M
$31.6M
Q4 24
$16.5M
Q3 24
$49.0M
$81.5M
Q2 24
$30.0M
$38.7M
Gross Margin
CNMD
CNMD
FOR
FOR
Q1 26
57.9%
Q4 25
58.5%
20.1%
Q3 25
49.2%
22.3%
Q2 25
55.0%
20.4%
Q1 25
55.3%
22.6%
Q4 24
57.3%
22.0%
Q3 24
56.5%
23.9%
Q2 24
55.3%
22.5%
Operating Margin
CNMD
CNMD
FOR
FOR
Q1 26
8.0%
Q4 25
9.8%
7.6%
Q3 25
3.5%
16.9%
Q2 25
11.1%
11.2%
Q1 25
5.0%
11.6%
Q4 24
15.2%
8.7%
Q3 24
20.7%
19.7%
Q2 24
14.2%
16.2%
Net Margin
CNMD
CNMD
FOR
FOR
Q1 26
4.4%
Q4 25
5.6%
Q3 25
0.8%
13.0%
Q2 25
6.3%
8.4%
Q1 25
1.9%
9.0%
Q4 24
6.6%
Q3 24
15.5%
14.8%
Q2 24
9.0%
12.2%
EPS (diluted)
CNMD
CNMD
FOR
FOR
Q1 26
$0.45
Q4 25
$0.54
$0.30
Q3 25
$0.09
$1.70
Q2 25
$0.69
$0.65
Q1 25
$0.19
$0.62
Q4 24
$1.09
$0.32
Q3 24
$1.57
$1.59
Q2 24
$0.96
$0.76

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CNMD
CNMD
FOR
FOR
Cash + ST InvestmentsLiquidity on hand
$211.7M
Total DebtLower is stronger
$793.2M
Stockholders' EquityBook value
$1.8B
Total Assets
$3.2B
Debt / EquityLower = less leverage
0.44×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CNMD
CNMD
FOR
FOR
Q1 26
Q4 25
$211.7M
Q3 25
$379.2M
Q2 25
$189.2M
Q1 25
$174.3M
Q4 24
$132.0M
Q3 24
$481.2M
Q2 24
$359.2M
Total Debt
CNMD
CNMD
FOR
FOR
Q1 26
Q4 25
$834.2M
$793.2M
Q3 25
$853.0M
$802.7M
Q2 25
$881.1M
$872.8M
Q1 25
$891.4M
$872.5M
Q4 24
$905.1M
$806.8M
Q3 24
$940.1M
$706.4M
Q2 24
$965.2M
$706.1M
Stockholders' Equity
CNMD
CNMD
FOR
FOR
Q1 26
Q4 25
$1.0B
$1.8B
Q3 25
$1.0B
$1.8B
Q2 25
$1.0B
$1.7B
Q1 25
$977.6M
$1.6B
Q4 24
$962.7M
$1.6B
Q3 24
$932.9M
$1.6B
Q2 24
$881.8M
$1.5B
Total Assets
CNMD
CNMD
FOR
FOR
Q1 26
Q4 25
$2.3B
$3.2B
Q3 25
$2.3B
$3.1B
Q2 25
$2.3B
$3.1B
Q1 25
$2.3B
$3.0B
Q4 24
$2.3B
$3.0B
Q3 24
$2.3B
$2.8B
Q2 24
$2.3B
$2.7B
Debt / Equity
CNMD
CNMD
FOR
FOR
Q1 26
Q4 25
0.81×
0.44×
Q3 25
0.85×
0.45×
Q2 25
0.88×
0.52×
Q1 25
0.91×
0.53×
Q4 24
0.94×
0.50×
Q3 24
1.01×
0.44×
Q2 24
1.09×
0.47×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CNMD
CNMD
FOR
FOR
Operating Cash FlowLast quarter
$-157.0M
Free Cash FlowOCF − Capex
$-157.1M
FCF MarginFCF / Revenue
-57.5%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
-10.19×
TTM Free Cash FlowTrailing 4 quarters
$93.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CNMD
CNMD
FOR
FOR
Q1 26
Q4 25
$46.3M
$-157.0M
Q3 25
$53.7M
$256.3M
Q2 25
$29.1M
$15.8M
Q1 25
$41.5M
$-19.8M
Q4 24
$43.3M
$-450.0M
Q3 24
$51.2M
$119.2M
Q2 24
$43.3M
$-61.7M
Free Cash Flow
CNMD
CNMD
FOR
FOR
Q1 26
Q4 25
$41.2M
$-157.1M
Q3 25
$48.5M
$255.6M
Q2 25
$23.4M
$15.0M
Q1 25
$37.8M
$-20.5M
Q4 24
$39.3M
Q3 24
$47.8M
$118.4M
Q2 24
$39.7M
$-62.3M
FCF Margin
CNMD
CNMD
FOR
FOR
Q1 26
Q4 25
11.0%
-57.5%
Q3 25
14.4%
38.1%
Q2 25
6.8%
3.8%
Q1 25
11.8%
-5.8%
Q4 24
11.4%
Q3 24
15.1%
21.5%
Q2 24
12.0%
-19.6%
Capex Intensity
CNMD
CNMD
FOR
FOR
Q1 26
Q4 25
1.4%
0.0%
Q3 25
1.5%
0.1%
Q2 25
1.7%
0.2%
Q1 25
1.2%
0.2%
Q4 24
1.2%
0.0%
Q3 24
1.1%
0.1%
Q2 24
1.1%
0.2%
Cash Conversion
CNMD
CNMD
FOR
FOR
Q1 26
Q4 25
-10.19×
Q3 25
18.78×
2.95×
Q2 25
1.36×
0.48×
Q1 25
6.88×
-0.63×
Q4 24
-27.27×
Q3 24
1.05×
1.46×
Q2 24
1.44×
-1.59×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CNMD
CNMD

Segment breakdown not available.

FOR
FOR

D.R.Horton Inc.$183.8M67%
Other$89.2M33%

Related Comparisons